spit.jpg

A collaboration between Google’s secretive life-extension spinoff and popular genetics company Ancestry has quietly ended

Business Insider

As is often the case in the world of scientific research partnerships, almost as quickly as a new deal begins, another ends.

Popular spit-in-a-tube genetics-testing company 23andMe made a splash last week when it announced a plan to share the anonymized genetic data of millions of consumers with pharmaceutical giant GlaxoSmithKline to help the company develop new drugs.

Ancestry, which maintains a database of genetic information built on the spit samples of more than 5 million consumers, had been partnering with Google's stealthy life extension spinoff Calico to study aging and longevity. The agreement, which was finalized almost exactly three years ago, recently ended, an Ancestry spokesperson told Business Insider.

Read the rest in Business Insider.